SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-116477
Filing Date
2022-11-09
Accepted
2022-11-09 16:12:06
Documents
14
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230110d1_8k.htm   iXBRL 8-K 30390
2 EXHIBIT 99.1 tm2230110d1_ex99-1.htm EX-99.1 35699
  Complete submission text file 0001104659-22-116477.txt   288001

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20221109.xsd EX-101.SCH 3280
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rzlt-20221109_def.xml EX-101.DEF 26452
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20221109_lab.xml EX-101.LAB 36200
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20221109_pre.xml EX-101.PRE 25110
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2230110d1_8k_htm.xml XML 4851
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 221372713
SIC: 2834 Pharmaceutical Preparations